Glenmark Life Sciences reports 18% fall in Q1 net profit

26 Jul 2024 Evaluate

Glenmark Life Sciences has reported results for first quarter ended June 30, 2024 (Q1FY25). 

The company has reported 17.70% fall in net profit at Rs 111.48 crore for Q1FY25 as compared to Rs 135.45 crore for the same quarter in the previous year. However, total income of the company increased by 2.38% at Rs 594.11 crore for Q1FY25 as compared to Rs 580.30 crore for the corresponding quarter previous year.

Glenmark Life Sciences is in the business of making high-quality drugs by unlocking the possibilities of science.


Alivus Life Sciences Share Price

907.15 1.75 (0.19%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×